Glucan

Asia Pacific Yeast Extracts and Beta-Glucan Market Report 2022: Rising Health Consciousness Among Consumers Set to Drive 8.4% Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022

The "Asia Pacific Yeast Extracts and Beta-Glucan Market Size, Share & Industry Trends Analysis Report By Type (Yeast Extract and Yeast Beta-Glucan), By Application, By Country and Growth Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia Pacific Yeast Extracts and Beta-Glucan Market Size, Share & Industry Trends Analysis Report By Type (Yeast Extract and Yeast Beta-Glucan), By Application, By Country and Growth Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • Despite the numerous advantages of yeast extracts and Beta-glucan, they might produce adverse reactions such as skin irritation, diarrhea, gas, bloating, and stomach discomfort when consumed.
  • Due to rising health consciousness among consumers along with increasing disposable incomes, the regional yeast extract and the beta-glucan market is expected to rise rapidly throughout the forecast period.
  • The China market dominated the Asia Pacific Yeast Extracts and Beta-Glucan Market by Country in 2021, and is expected to continue to be a dominant market till 2018; thereby, achieving a market value of $182.4 Million by 2028.

Life Extension Launches Mushroom Immune with Beta Glucans

Retrieved on: 
Tuesday, June 15, 2021

These findings were the impetus behind the launch of Life Extensions formula, Mushroom Immune with Beta Glucans .

Key Points: 
  • These findings were the impetus behind the launch of Life Extensions formula, Mushroom Immune with Beta Glucans .
  • According to Life Extensions Director of Education, Michael A. Smith, MD , the specific combination of these nutrients offers complete support.
  • Its also why Life Extension added beta-glucans, a soluble fiber compound thats been shown through numerous clinical studies to support immune balance.
  • Life Extensions Mushroom Immune with Beta Glucans formula is gluten-free, vegetarian and non-GMO, and it comes in easy-to-swallow, once-daily capsules.

Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights

Retrieved on: 
Thursday, May 20, 2021

To date, with outreach initiatives put in place by the team at the Montreal Heart Institute, more than 200 patients are part of the study.

Key Points: 
  • To date, with outreach initiatives put in place by the team at the Montreal Heart Institute, more than 200 patients are part of the study.
  • Subsequent to quarter end, the Company announced the successful completion of its long-term research collaboration with University of Alberta.
  • This project allowed for the expansion of a PGX pipeline which now includes proteins/enzymes in addition to polysaccharides like beta glucan.
  • Timelines and cost estimates are being assessed.\nFinancial Highlights for the First Quarter Ended March 31, 2021\nTotal sales of $4,702,000 for the first quarter of 2021 compared to $4,273,000 for the comparative period in 2020; an increase of 10% over last year.

Kemin Granted U.S. Patent for Treatment of Human Immune Function

Retrieved on: 
Tuesday, May 4, 2021

"In particular, the Kemin proprietary strain of Euglena gracilis has shown especially robust immune support stemming from its high content of beta 1,3 glucan.

Key Points: 
  • "In particular, the Kemin proprietary strain of Euglena gracilis has shown especially robust immune support stemming from its high content of beta 1,3 glucan.
  • "\nKemin\'s BetaVia Complete and BetaVia Pure ingredients are sourced from proprietary Euglena gracilis algae.
  • BetaVia Complete is nutritionally rich, with a composition of greater than 50 percent beta 1,3 glucan, protein (greater than 15 percent), fatty acids, vitamins, minerals and carotenoids.
  • TM Trademarks of Kemin Industries, Inc., U.S.A. Certain statements, product labeling and claims may differ by geography or as required by government requirements.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/kemin-granted-us-patent-for-trea...\n'

Beta-Glucan Market worth $628.3 million by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, March 23, 2021

Factors such as the increasing research on beta-glucan, clubbed with its functional benefits has been the key areas that has supported the market growth of beta-glucan.

Key Points: 
  • Factors such as the increasing research on beta-glucan, clubbed with its functional benefits has been the key areas that has supported the market growth of beta-glucan.
  • It is also used across other application areas such as nutraceuticals, cosmetics, personal care, and animal feed.
  • Soluble dietary fibers also reduce the total plasma cholesterol and lower the glycemic index of food providing numerous health benefits.
  • The key market players in the North American beta-glucan market include Cargill (U.S.), Millipore Sigma (U.S.), and Lesaffre (U.S.).

Beta-Glucan Market worth $628.3 million by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, March 23, 2021

Factors such as the increasing research on beta-glucan, clubbed with its functional benefits has been the key areas that has supported the market growth of beta-glucan.

Key Points: 
  • Factors such as the increasing research on beta-glucan, clubbed with its functional benefits has been the key areas that has supported the market growth of beta-glucan.
  • It is also used across other application areas such as nutraceuticals, cosmetics, personal care, and animal feed.
  • Soluble dietary fibers also reduce the total plasma cholesterol and lower the glycemic index of food providing numerous health benefits.
  • The key market players in the North American beta-glucan market include Cargill (U.S.), Millipore Sigma (U.S.), and Lesaffre (U.S.).

Avmacol® Helps Consumers Unleash ‘You Power’ with New Campaign to Promote the Health Benefits of Sulforaphane

Retrieved on: 
Tuesday, November 10, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201110005836/en/
    Avmacol Extra Strength unleashes the power of broccoli and beta-glucans to provide further immune and detoxification support.
  • (Photo: Business Wire)
    Avmacol Extra Strength unleashes the power of broccoli and beta-glucans to give ones immune system extra support, said Dr.
  • Troy Henderson, president and CEO at Nutramax Laboratories Consumer Care, Inc. We hope consumers will better understand how the bodys immune and detoxification systems work, and ultimately how Avmacol Extra Strength will help promote health and wellness.
  • For more information on sulforaphane and Avmacol Extra Strength, please visit the companys website or Amazon product page .

Prophylaxis to COVID-19 by AFO-202 ß-Glucan Food Supplement From Japan

Retrieved on: 
Monday, October 26, 2020

Higher mortality has been reported in patients, whose fasting plasma glucose is very high at the time of hospital admission with SARS-COV-2.

Key Points: 
  • Higher mortality has been reported in patients, whose fasting plasma glucose is very high at the time of hospital admission with SARS-COV-2.
  • View the full release here: https://www.businesswire.com/news/home/20201025005031/en/
    Salient features of AFO-202 secreted Nichi-Glucan on its potentials of prophylaxis to Covid-19 related complications through Blood glucose, cholesterol and coagulation system balancing.
  • Nichi Glucan is available in Japan ( www.nichiglucan.com ) and in India ( https://www.amazon.in/dp/B08DFDX2HQ ), exported worldwide by GN Corporation.
  • Disclaimer: Nichi-Glucan is a food supplement, free from 25 most common allergens.

SCYNEXIS Announces Presentations at 2020 IDSOG Virtual Annual Meeting Highlighting Ibrexafungerp’s Potential for the Treatment of Vulvovaginal Candidiasis

Retrieved on: 
Thursday, August 13, 2020

Ibrexafungerp [pronounced eye-BREX-ah-FUN-jerp] is an investigational antifungal agent and the first representative of a novel class of structurally distinct glucan synthase inhibitors, triterpenoids.

Key Points: 
  • Ibrexafungerp [pronounced eye-BREX-ah-FUN-jerp] is an investigational antifungal agent and the first representative of a novel class of structurally distinct glucan synthase inhibitors, triterpenoids.
  • This agent combines the well-established activity of glucan synthase inhibitors with the potential flexibility of having oral and intravenous (IV) formulations.
  • Ibrexafungerp is currently in development for the treatment of fungal infections caused primarily by Candida (including C. auris) and Aspergillus species.
  • SCYNEXIS undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Introducing Fungitell STAT™ a single sample test used in the diagnosis of Invasive Fungal Infections

Retrieved on: 
Monday, August 3, 2020

(13)--D-glucan is produced by common primary human fungal pathogens such as Candida spp., Aspergillus spp.

Key Points: 
  • (13)--D-glucan is produced by common primary human fungal pathogens such as Candida spp., Aspergillus spp.
  • and Pneumocystis spp., as well as many opportunistic fungal pathogens.
  • ACC is one of the world's largest manufacturers of products developed to detect and quantify Gram-negative bacterial endotoxins and (13)--D-glucans.
  • Our products are used worldwide by leading pharmaceutical and medical device companies to ensure the safety of their parenteral drugs, biological products and medical devices.